fanta.bio Sample: CNhs11718
17313 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1318 / 19976 (6.6%) | 469 / 199760 (0.2%) | −324.0 | −324.0 | 28.10 |
| HIF1A SRX11007095 | HK-2 Kidney | 2629 / 19976 (13.2%) | 976 / 199760 (0.5%) | −324.0 | −324.0 | 26.94 |
| TP53 SRX19538274 | U2OS Bone | 492 / 19976 (2.5%) | 187 / 199760 (0.1%) | −324.0 | −324.0 | 26.31 |
| TP53 SRX19538268 | U2OS Bone | 481 / 19976 (2.4%) | 195 / 199760 (0.1%) | −324.0 | −324.0 | 24.67 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 2015 / 19976 (10.1%) | 824 / 199760 (0.4%) | −324.0 | −324.0 | 24.45 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1922 / 19976 (9.6%) | 795 / 199760 (0.4%) | −324.0 | −324.0 | 24.18 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2852 / 19976 (14.3%) | 1191 / 199760 (0.6%) | −324.0 | −324.0 | 23.95 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2779 / 19976 (13.9%) | 1188 / 199760 (0.6%) | −324.0 | −324.0 | 23.39 |
| TP53 SRX19538276 | U2OS Bone | 480 / 19976 (2.4%) | 210 / 199760 (0.1%) | −324.0 | −324.0 | 22.86 |
| FOXP1 SRX736067 | LNCAP Prostate | 2433 / 19976 (12.2%) | 1095 / 199760 (0.5%) | −324.0 | −324.0 | 22.22 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 492 / 19976 (2.5%) | 231 / 199760 (0.1%) | −324.0 | −324.0 | 21.30 |
| HIF1A SRX20663235 | HK-2 Kidney | 609 / 19976 (3.0%) | 286 / 199760 (0.1%) | −324.0 | −324.0 | 21.29 |
| SCML2 SRX644728 | 293 Kidney | 1632 / 19976 (8.2%) | 803 / 199760 (0.4%) | −324.0 | −324.0 | 20.32 |
| TP53 SRX19538279 | Osteoblasts Bone | 603 / 19976 (3.0%) | 305 / 199760 (0.2%) | −324.0 | −324.0 | 19.77 |
| MYH11 SRX265221 | ME-1 Blood | 1070 / 19976 (5.4%) | 635 / 199760 (0.3%) | −324.0 | −324.0 | 16.85 |
| BRD4 SRX9419935 | BT-474 Breast | 4298 / 19976 (21.5%) | 3013 / 199760 (1.5%) | −324.0 | −324.0 | 14.26 |
| BRD4 SRX9419937 | BT-474 Breast | 4298 / 19976 (21.5%) | 3037 / 199760 (1.5%) | −324.0 | −324.0 | 14.15 |
| MED1 SRX9419944 | BT-474 Breast | 4182 / 19976 (20.9%) | 2989 / 199760 (1.5%) | −324.0 | −324.0 | 13.99 |
| MED1 SRX9419945 | BT-474 Breast | 4266 / 19976 (21.4%) | 3065 / 199760 (1.5%) | −324.0 | −324.0 | 13.92 |
| MED1 SRX9419947 | BT-474 Breast | 4228 / 19976 (21.2%) | 3125 / 199760 (1.6%) | −324.0 | −324.0 | 13.53 |
| MED1 SRX9419946 | BT-474 Breast | 4342 / 19976 (21.7%) | 3214 / 199760 (1.6%) | −324.0 | −324.0 | 13.51 |
| BRD4 SRX9419936 | BT-474 Breast | 4336 / 19976 (21.7%) | 3214 / 199760 (1.6%) | −324.0 | −324.0 | 13.49 |
| BRD4 SRX9419938 | BT-474 Breast | 4299 / 19976 (21.5%) | 3188 / 199760 (1.6%) | −324.0 | −324.0 | 13.48 |
| EZH2 SRX2146136 | LNCAP Prostate | 9647 / 19976 (48.3%) | 8884 / 199760 (4.4%) | −324.0 | −324.0 | 10.86 |
| BRD4 SRX736201 | 90-8TL Neural | 7100 / 19976 (35.5%) | 7412 / 199760 (3.7%) | −324.0 | −324.0 | 9.58 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2198 / 19976 (11.0%) | 3033 / 199760 (1.5%) | −324.0 | −324.0 | 7.25 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1522 / 19976 (7.6%) | 4284 / 199760 (2.1%) | −324.0 | −324.0 | 3.55 |
| PBX4 SRX2731658 | PC-3 Prostate | 1275 / 19976 (6.4%) | 31401 / 199760 (15.7%) | −324.0 | −324.0 | 0.41 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 807 / 19976 (4.0%) | 1148 / 199760 (0.6%) | −318.9 | −315.8 | 7.03 |
| TP53 SRX19538280 | Osteoblasts Bone | 474 / 19976 (2.4%) | 231 / 199760 (0.1%) | −313.0 | −310.0 | 20.52 |
| TP53 SRX19538281 | Osteoblasts Bone | 510 / 19976 (2.6%) | 324 / 199760 (0.2%) | −306.3 | −303.3 | 15.74 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 760 / 19976 (3.8%) | 1070 / 199760 (0.5%) | −302.3 | −299.2 | 7.10 |
| TP53 SRX19538275 | U2OS Bone | 439 / 19976 (2.2%) | 189 / 199760 (0.1%) | −301.4 | −298.4 | 23.23 |
| TP53 SRX19538267 | U2OS Bone | 429 / 19976 (2.1%) | 178 / 199760 (0.1%) | −297.7 | −294.8 | 24.10 |
| TP53 SRX19538273 | U2OS Bone | 425 / 19976 (2.1%) | 174 / 199760 (0.1%) | −296.1 | −293.1 | 24.43 |
| TP53 SRX19538269 | U2OS Bone | 549 / 19976 (2.7%) | 480 / 199760 (0.2%) | −286.9 | −283.9 | 11.44 |
| AGO2 SRX4708039 | Hep G2 Liver | 2178 / 19976 (10.9%) | 8724 / 199760 (4.4%) | −281.2 | −278.3 | 2.50 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1733 / 19976 (8.7%) | 6021 / 199760 (3.0%) | −279.9 | −276.9 | 2.88 |
| ESR1 SRX7624157 | MCF-7 Breast | 932 / 19976 (4.7%) | 24493 / 199760 (12.3%) | −275.5 | −272.6 | 0.38 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1245 / 19976 (6.2%) | 28790 / 199760 (14.4%) | −269.0 | −266.1 | 0.43 |
| TP53 SRX19538270 | U2OS Bone | 522 / 19976 (2.6%) | 473 / 199760 (0.2%) | −268.0 | −265.1 | 11.04 |
| FOS SRX150477 | MCF 10A Breast | 888 / 19976 (4.4%) | 23413 / 199760 (11.7%) | −263.4 | −260.5 | 0.38 |
| Epitope tags SRX10549776 | K-562 Blood | 1683 / 19976 (8.4%) | 5978 / 199760 (3.0%) | −262.3 | −259.4 | 2.82 |
| FOXA1 SRX176862 | MCF-7 Breast | 457 / 19976 (2.3%) | 16498 / 199760 (8.3%) | −262.2 | −259.3 | 0.28 |
| FOS SRX150478 | MCF 10A Breast | 948 / 19976 (4.7%) | 24079 / 199760 (12.1%) | −257.1 | −254.3 | 0.39 |
| ESR1 SRX371478 | MCF-7 Breast | 459 / 19976 (2.3%) | 16365 / 199760 (8.2%) | −256.7 | −253.9 | 0.28 |
| FOXA1 SRX176863 | MCF-7 Breast | 428 / 19976 (2.1%) | 15752 / 199760 (7.9%) | −254.3 | −251.5 | 0.27 |
| FOXA1 SRX4815197 | MCF-7 Breast | 924 / 19976 (4.6%) | 23602 / 199760 (11.8%) | −253.7 | −250.9 | 0.39 |
| ESR1 SRX371469 | MCF-7 Breast | 358 / 19976 (1.8%) | 14496 / 199760 (7.3%) | −253.7 | −250.8 | 0.25 |
| ESR1 SRX20282961 | MCF-7 Breast | 453 / 19976 (2.3%) | 16150 / 199760 (8.1%) | −253.2 | −250.4 | 0.28 |
| IRF3 SRX11453858 | Hep G2 Liver | 326 / 19976 (1.6%) | 87 / 199760 (0.0%) | −253.1 | −250.2 | 37.47 |
| ESR1 SRX4367193 | MCF-7 Breast | 1255 / 19976 (6.3%) | 28193 / 199760 (14.1%) | −249.5 | −246.7 | 0.45 |
| ESR1 SRX7624156 | MCF-7 Breast | 598 / 19976 (3.0%) | 18415 / 199760 (9.2%) | −248.7 | −245.9 | 0.32 |
| GATA3 SRX190239 | MCF-7 Breast | 541 / 19976 (2.7%) | 17451 / 199760 (8.7%) | −247.7 | −244.9 | 0.31 |
| TP53 SRX19538282 | Osteoblasts Bone | 443 / 19976 (2.2%) | 339 / 199760 (0.2%) | −246.1 | −243.4 | 13.07 |
| KAT7 SRX101303 | RKO Digestive tract | 1638 / 19976 (8.2%) | 5961 / 199760 (3.0%) | −245.4 | −242.6 | 2.75 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 429 / 19976 (2.1%) | 15424 / 199760 (7.7%) | −243.2 | −240.5 | 0.28 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 583 / 19976 (2.9%) | 767 / 199760 (0.4%) | −242.1 | −239.4 | 7.60 |
| ESR1 SRX176860 | MCF-7 Breast | 629 / 19976 (3.1%) | 18639 / 199760 (9.3%) | −240.6 | −237.9 | 0.34 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 675 / 19976 (3.4%) | 1120 / 199760 (0.6%) | −238.0 | −235.2 | 6.03 |
| ESR1 SRX176861 | MCF-7 Breast | 638 / 19976 (3.2%) | 18684 / 199760 (9.4%) | −237.8 | −235.1 | 0.34 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 552 / 19976 (2.8%) | 17283 / 199760 (8.7%) | −237.1 | −234.3 | 0.32 |
| FOXA1 SRX1161177 | MCF-7 Breast | 377 / 19976 (1.9%) | 14323 / 199760 (7.2%) | −237.0 | −234.3 | 0.26 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 885 / 19976 (4.4%) | 22267 / 199760 (11.1%) | −232.6 | −229.9 | 0.40 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 445 / 19976 (2.2%) | 15345 / 199760 (7.7%) | −232.1 | −229.4 | 0.29 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 667 / 19976 (3.3%) | 18943 / 199760 (9.5%) | −232.0 | −229.3 | 0.35 |
| ESR1 SRX371479 | MCF-7 Breast | 346 / 19976 (1.7%) | 13613 / 199760 (6.8%) | −231.7 | −229.0 | 0.25 |
| BRD1 SRX286203 | RKO Digestive tract | 1404 / 19976 (7.0%) | 4803 / 199760 (2.4%) | −230.1 | −227.5 | 2.92 |
| ESR1 SRX20282960 | MCF-7 Breast | 442 / 19976 (2.2%) | 15234 / 199760 (7.6%) | −230.1 | −227.4 | 0.29 |
| TP53 SRX19538271 | U2OS Bone | 743 / 19976 (3.7%) | 1445 / 199760 (0.7%) | −229.9 | −227.3 | 5.14 |
| FOXA1 SRX371481 | MCF-7 Breast | 408 / 19976 (2.0%) | 14632 / 199760 (7.3%) | −229.6 | −226.9 | 0.28 |
| FOXA1 SRX3931044 | MCF-7 Breast | 860 / 19976 (4.3%) | 21766 / 199760 (10.9%) | −229.1 | −226.4 | 0.40 |
| TLE3 SRX4815191 | MCF-7 Breast | 369 / 19976 (1.8%) | 13913 / 199760 (7.0%) | −228.3 | −225.6 | 0.27 |
| ESR1 SRX20282939 | MCF-7 Breast | 447 / 19976 (2.2%) | 15174 / 199760 (7.6%) | −225.6 | −223.0 | 0.29 |
| FOXA1 SRX371483 | MCF-7 Breast | 450 / 19976 (2.3%) | 15175 / 199760 (7.6%) | −224.1 | −221.4 | 0.30 |
| FOS SRX4192880 | MCF 10A Breast | 693 / 19976 (3.5%) | 19064 / 199760 (9.5%) | −224.0 | −221.3 | 0.36 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 570 / 19976 (2.9%) | 17132 / 199760 (8.6%) | −223.9 | −221.3 | 0.33 |
| FOXA1 SRX371482 | MCF-7 Breast | 581 / 19976 (2.9%) | 17299 / 199760 (8.7%) | −223.5 | −220.9 | 0.34 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1064 / 19976 (5.3%) | 24476 / 199760 (12.3%) | −222.6 | −220.0 | 0.43 |
| ESR1 SRX371476 | MCF-7 Breast | 278 / 19976 (1.4%) | 12075 / 199760 (6.0%) | −222.0 | −219.4 | 0.23 |
| FOXA1 SRX1161176 | MCF-7 Breast | 376 / 19976 (1.9%) | 13834 / 199760 (6.9%) | −221.9 | −219.3 | 0.27 |
| FOXA1 SRX1161173 | MCF-7 Breast | 306 / 19976 (1.5%) | 12510 / 199760 (6.3%) | −219.4 | −216.8 | 0.24 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1221 / 19976 (6.1%) | 26520 / 199760 (13.3%) | −218.7 | −216.1 | 0.46 |
| ESR1 SRX194569 | MCF-7 Breast | 414 / 19976 (2.1%) | 14346 / 199760 (7.2%) | −217.3 | −214.7 | 0.29 |
| ESR1 SRX371467 | MCF-7 Breast | 419 / 19976 (2.1%) | 14408 / 199760 (7.2%) | −216.6 | −214.0 | 0.29 |
| ESR1 SRX371471 | ZR-75-1 Breast | 436 / 19976 (2.2%) | 14687 / 199760 (7.4%) | −216.4 | −213.8 | 0.30 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 383 / 19976 (1.9%) | 13767 / 199760 (6.9%) | −215.8 | −213.2 | 0.28 |
| ESR1 SRX1531791 | MCF-7 Breast | 386 / 19976 (1.9%) | 13798 / 199760 (6.9%) | −215.1 | −212.5 | 0.28 |
| IRF3 SRX11453861 | Hep G2 Liver | 286 / 19976 (1.4%) | 88 / 199760 (0.0%) | −214.9 | −212.4 | 32.50 |
| YAP1 SRX757325 | H2052 Lung | 1075 / 19976 (5.4%) | 24304 / 199760 (12.2%) | −214.2 | −211.6 | 0.44 |
| ESR1 SRX20282972 | MCF-7 Breast | 454 / 19976 (2.3%) | 14889 / 199760 (7.5%) | −213.3 | −210.8 | 0.30 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 565 / 19976 (2.8%) | 861 / 199760 (0.4%) | −212.1 | −209.5 | 6.56 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 309 / 19976 (1.5%) | 12308 / 199760 (6.2%) | −210.9 | −208.4 | 0.25 |
| ESR1 SRX371470 | ZR-75-1 Breast | 368 / 19976 (1.8%) | 13349 / 199760 (6.7%) | −210.9 | −208.3 | 0.28 |
| FOXA1 SRX1161175 | MCF-7 Breast | 300 / 19976 (1.5%) | 12096 / 199760 (6.1%) | −209.4 | −206.9 | 0.25 |
| BRPF3 SRX796084 | RKO Digestive tract | 1734 / 19976 (8.7%) | 7161 / 199760 (3.6%) | −209.0 | −206.5 | 2.42 |
| BRD4 SRX736204 | 90-8TL Neural | 1095 / 19976 (5.5%) | 3376 / 199760 (1.7%) | −206.7 | −204.2 | 3.24 |
| ESR1 SRX20282954 | MCF-7 Breast | 453 / 19976 (2.3%) | 14632 / 199760 (7.3%) | −205.9 | −203.4 | 0.31 |
| ESR1 SRX10365535 | MCF-7 Breast | 320 / 19976 (1.6%) | 12334 / 199760 (6.2%) | −205.4 | −202.8 | 0.26 |
| GATA3 SRX5057632 | MCF-7 Breast | 256 / 19976 (1.3%) | 11160 / 199760 (5.6%) | −205.3 | −202.8 | 0.23 |
| ESR1 SRX194572 | MCF-7 Breast | 251 / 19976 (1.3%) | 11067 / 199760 (5.5%) | −205.2 | −202.7 | 0.23 |
| AR SRX10820653 | LNCAP Prostate | 357 / 19976 (1.8%) | 253 / 199760 (0.1%) | −205.0 | −202.5 | 14.11 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 742 / 19976 (3.7%) | 1631 / 199760 (0.8%) | −205.0 | −202.5 | 4.55 |
| ESR1 SRX371468 | MCF-7 Breast | 256 / 19976 (1.3%) | 11139 / 199760 (5.6%) | −204.5 | −202.0 | 0.23 |
| GATA3 SRX176864 | MCF-7 Breast | 294 / 19976 (1.5%) | 11836 / 199760 (5.9%) | −204.4 | −201.9 | 0.25 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 541 / 19976 (2.7%) | 16003 / 199760 (8.0%) | −204.3 | −201.8 | 0.34 |
| BRPF3 SRX796085 | RKO Digestive tract | 1235 / 19976 (6.2%) | 4192 / 199760 (2.1%) | −204.1 | −201.6 | 2.95 |
| ESR1 SRX2943591 | MCF-7 Breast | 274 / 19976 (1.4%) | 11445 / 199760 (5.7%) | −203.6 | −201.1 | 0.24 |
| ARID1A SRX5089376 | MCF-7 Breast | 352 / 19976 (1.8%) | 12832 / 199760 (6.4%) | −203.3 | −200.9 | 0.27 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 307 / 19976 (1.5%) | 12037 / 199760 (6.0%) | −203.3 | −200.8 | 0.26 |
| BRPF3 SRX796086 | RKO Digestive tract | 1652 / 19976 (8.3%) | 6792 / 199760 (3.4%) | −200.3 | −197.8 | 2.43 |
| ESR1 SRX10365536 | MCF-7 Breast | 205 / 19976 (1.0%) | 10027 / 199760 (5.0%) | −200.0 | −197.6 | 0.20 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1538 / 19976 (7.7%) | 29992 / 199760 (15.0%) | −199.7 | −197.2 | 0.51 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 388 / 19976 (1.9%) | 13324 / 199760 (6.7%) | −199.2 | −196.7 | 0.29 |
| FOXA1 SRX1787653 | MCF-7 Breast | 339 / 19976 (1.7%) | 12459 / 199760 (6.2%) | −198.7 | −196.2 | 0.27 |
| TLE3 SRX4815192 | MCF-7 Breast | 371 / 19976 (1.9%) | 13008 / 199760 (6.5%) | −198.5 | −196.0 | 0.29 |
| FOXA1 SRX371480 | MCF-7 Breast | 284 / 19976 (1.4%) | 11458 / 199760 (5.7%) | −198.0 | −195.5 | 0.25 |
| ESR1 SRX371477 | MCF-7 Breast | 192 / 19976 (1.0%) | 9696 / 199760 (4.9%) | −197.4 | −195.0 | 0.20 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 290 / 19976 (1.5%) | 129 / 199760 (0.1%) | −197.1 | −194.7 | 22.48 |
| ESR1 SRX20282973 | MCF-7 Breast | 517 / 19976 (2.6%) | 15361 / 199760 (7.7%) | −196.7 | −194.3 | 0.34 |
| FOS SRX150517 | MCF 10A Breast | 751 / 19976 (3.8%) | 18951 / 199760 (9.5%) | −196.4 | −193.9 | 0.40 |
| RAC1 SRX10365543 | MCF-7 Breast | 209 / 19976 (1.0%) | 9985 / 199760 (5.0%) | −195.9 | −193.5 | 0.21 |
| 5-mC SRX882970 | LNCAP Prostate | 3208 / 19976 (16.1%) | 18014 / 199760 (9.0%) | −195.7 | −193.2 | 1.78 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1667 / 19976 (8.3%) | 31484 / 199760 (15.8%) | −195.4 | −193.0 | 0.53 |
| ESR1 SRX20282955 | MCF-7 Breast | 450 / 19976 (2.3%) | 14226 / 199760 (7.1%) | −195.3 | −192.8 | 0.32 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 395 / 19976 (2.0%) | 13277 / 199760 (6.6%) | −194.1 | −191.7 | 0.30 |
| FOXA1 SRX100454 | T-47D Breast | 562 / 19976 (2.8%) | 15981 / 199760 (8.0%) | −194.0 | −191.6 | 0.35 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 388 / 19976 (1.9%) | 13150 / 199760 (6.6%) | −193.9 | −191.5 | 0.30 |
| ESR1 SRX4367192 | MCF-7 Breast | 892 / 19976 (4.5%) | 20903 / 199760 (10.5%) | −193.6 | −191.2 | 0.43 |
| FOS SRX150476 | MCF 10A Breast | 766 / 19976 (3.8%) | 19058 / 199760 (9.5%) | −193.3 | −190.9 | 0.40 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 338 / 19976 (1.7%) | 12257 / 199760 (6.1%) | −192.9 | −190.5 | 0.28 |
| FOXA1 SRX1161174 | MCF-7 Breast | 450 / 19976 (2.3%) | 14093 / 199760 (7.1%) | −191.2 | −188.8 | 0.32 |
| RAC1 SRX10365541 | MCF-7 Breast | 218 / 19976 (1.1%) | 10015 / 199760 (5.0%) | −191.0 | −188.6 | 0.22 |
| ARID1A SRX5089379 | MCF-7 Breast | 425 / 19976 (2.1%) | 13664 / 199760 (6.8%) | −190.7 | −188.3 | 0.31 |
| ESR1 SRX20282940 | MCF-7 Breast | 475 / 19976 (2.4%) | 14469 / 199760 (7.2%) | −190.3 | −187.9 | 0.33 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 433 / 19976 (2.2%) | 13782 / 199760 (6.9%) | −190.2 | −187.8 | 0.31 |
| FOXA1 SRX3923514 | MCF-7 Breast | 442 / 19976 (2.2%) | 13927 / 199760 (7.0%) | −190.2 | −187.8 | 0.32 |
| ESR1 SRX2881002 | MCF-7 Breast | 410 / 19976 (2.1%) | 13369 / 199760 (6.7%) | −189.3 | −186.9 | 0.31 |
| YAP1 SRX757326 | H2052 Lung | 961 / 19976 (4.8%) | 21697 / 199760 (10.9%) | −188.7 | −186.3 | 0.44 |
| ESR1 SRX10365532 | MCF-7 Breast | 222 / 19976 (1.1%) | 10005 / 199760 (5.0%) | −188.0 | −185.7 | 0.22 |
| 5-mC SRX882968 | LNCAP Prostate | 3158 / 19976 (15.8%) | 17865 / 199760 (8.9%) | −188.0 | −185.6 | 1.77 |
| ESR1 SRX2881000 | MCF-7 Breast | 382 / 19976 (1.9%) | 12849 / 199760 (6.4%) | −187.8 | −185.4 | 0.30 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 472 / 19976 (2.4%) | 14329 / 199760 (7.2%) | −187.6 | −185.2 | 0.33 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 969 / 19976 (4.9%) | 21762 / 199760 (10.9%) | −187.5 | −185.2 | 0.45 |
| CEBPA SRX2630241 | Hep G2 Liver | 527 / 19976 (2.6%) | 15205 / 199760 (7.6%) | −187.5 | −185.1 | 0.35 |
| ESR1 SRX10365533 | MCF-7 Breast | 187 / 19976 (0.9%) | 9297 / 199760 (4.7%) | −187.1 | −184.7 | 0.20 |
| STAT5B SRX831881 | CD8+ T cells Blood | 291 / 19976 (1.5%) | 155 / 199760 (0.1%) | −186.5 | −184.1 | 18.77 |
| NR2F2 SRX190293 | MCF-7 Breast | 462 / 19976 (2.3%) | 14123 / 199760 (7.1%) | −186.3 | −184.0 | 0.33 |
| ESR1 SRX20282946 | MCF-7 Breast | 254 / 19976 (1.3%) | 10523 / 199760 (5.3%) | −185.3 | −183.0 | 0.24 |
| FOXA2 SRX3230382 | Hep G2 Liver | 606 / 19976 (3.0%) | 16328 / 199760 (8.2%) | −184.6 | −182.2 | 0.37 |
| JUNB SRX8488088 | SUM 229PE Breast | 880 / 19976 (4.4%) | 20364 / 199760 (10.2%) | −184.1 | −181.7 | 0.43 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 310 / 19976 (1.6%) | 11484 / 199760 (5.7%) | −183.9 | −181.6 | 0.27 |
| FOXA1 SRX11222437 | MCF-7 Breast | 313 / 19976 (1.6%) | 11532 / 199760 (5.8%) | −183.8 | −181.5 | 0.27 |
| AGO2 SRX6783957 | Hep G2 Liver | 1360 / 19976 (6.8%) | 5260 / 199760 (2.6%) | −182.7 | −180.3 | 2.59 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 412 / 19976 (2.1%) | 13173 / 199760 (6.6%) | −182.4 | −180.1 | 0.31 |
| ING5 SRX286202 | RKO Digestive tract | 1487 / 19976 (7.4%) | 6073 / 199760 (3.0%) | −181.7 | −179.4 | 2.45 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 743 / 19976 (3.7%) | 18282 / 199760 (9.2%) | −181.7 | −179.3 | 0.41 |
| LEO1 SRX1873456 | SEM Blood | 1638 / 19976 (8.2%) | 7065 / 199760 (3.5%) | −181.0 | −178.6 | 2.32 |
| ESR1 SRX330067 | MCF-7 Breast | 403 / 19976 (2.0%) | 12966 / 199760 (6.5%) | −180.8 | −178.4 | 0.31 |
| ESR1 SRX20282971 | MCF-7 Breast | 445 / 19976 (2.2%) | 13652 / 199760 (6.8%) | −180.6 | −178.3 | 0.33 |
| ESR1 SRX5323873 | MCF-7 Breast | 553 / 19976 (2.8%) | 15363 / 199760 (7.7%) | −180.4 | −178.1 | 0.36 |
| AGO2 SRX6783958 | Hep G2 Liver | 1334 / 19976 (6.7%) | 5164 / 199760 (2.6%) | −178.8 | −176.5 | 2.58 |
| ESR1 SRX3110725 | MCF-7 Breast | 403 / 19976 (2.0%) | 12899 / 199760 (6.5%) | −178.7 | −176.3 | 0.31 |
| CEBPB SRX150632 | HeLa Uterus | 1022 / 19976 (5.1%) | 22144 / 199760 (11.1%) | −178.6 | −176.3 | 0.46 |
| ESR1 SRX10365558 | MCF-7 Breast | 296 / 19976 (1.5%) | 11046 / 199760 (5.5%) | −177.9 | −175.6 | 0.27 |
| ESR1 SRX330070 | MCF-7 Breast | 221 / 19976 (1.1%) | 9679 / 199760 (4.8%) | −177.8 | −175.5 | 0.23 |
| ARID5B SRX3230377 | Hep G2 Liver | 1139 / 19976 (5.7%) | 23716 / 199760 (11.9%) | −177.6 | −175.3 | 0.48 |
| FOS SRX4192879 | MCF 10A Breast | 535 / 19976 (2.7%) | 14966 / 199760 (7.5%) | −177.1 | −174.8 | 0.36 |
| RUNX1 SRX2513054 | 293 Kidney | 3511 / 19976 (17.6%) | 20990 / 199760 (10.5%) | −177.1 | −174.8 | 1.67 |
| FOXA1 SRX5323843 | MCF-7 Breast | 222 / 19976 (1.1%) | 9671 / 199760 (4.8%) | −177.0 | −174.7 | 0.23 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 212 / 19976 (1.1%) | 9482 / 199760 (4.7%) | −176.9 | −174.6 | 0.22 |
| ESR1 SRX2912055 | MCF-7 Breast | 156 / 19976 (0.8%) | 8377 / 199760 (4.2%) | −176.7 | −174.5 | 0.19 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 599 / 19976 (3.0%) | 15922 / 199760 (8.0%) | −176.2 | −173.9 | 0.38 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1588 / 19976 (7.9%) | 29596 / 199760 (14.8%) | −176.1 | −173.8 | 0.54 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 434 / 19976 (2.2%) | 13313 / 199760 (6.7%) | −175.9 | −173.6 | 0.33 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 680 / 19976 (3.4%) | 1598 / 199760 (0.8%) | −175.5 | −173.3 | 4.26 |
| FOXA1 SRX3931055 | MCF-7 Breast | 385 / 19976 (1.9%) | 12490 / 199760 (6.3%) | −175.4 | −173.2 | 0.31 |
| FOXA1 SRX3931043 | MCF-7 Breast | 468 / 19976 (2.3%) | 13847 / 199760 (6.9%) | −175.4 | −173.1 | 0.34 |
| Epitope tags DRX443510 | 293 Kidney | 1644 / 19976 (8.2%) | 7218 / 199760 (3.6%) | −175.3 | −173.0 | 2.28 |
| ESR1 SRX8537722 | MCF-7 Breast | 424 / 19976 (2.1%) | 13116 / 199760 (6.6%) | −174.9 | −172.7 | 0.32 |
| AR SRX10820651 | LNCAP Prostate | 367 / 19976 (1.8%) | 383 / 199760 (0.2%) | −174.9 | −172.6 | 9.58 |
| GATA3 SRX6712581 | MCF-7 Breast | 374 / 19976 (1.9%) | 12274 / 199760 (6.1%) | −174.4 | −172.2 | 0.30 |
| TP53 SRX396254 | Fibroblasts Others | 981 / 19976 (4.9%) | 3155 / 199760 (1.6%) | −174.4 | −172.1 | 3.11 |
| FOXA1 SRX1787651 | MCF-7 Breast | 251 / 19976 (1.3%) | 10126 / 199760 (5.1%) | −174.2 | −171.9 | 0.25 |
| ESR1 SRX4451213 | MCF-7 Breast | 465 / 19976 (2.3%) | 13749 / 199760 (6.9%) | −174.1 | −171.8 | 0.34 |
| CEBPB SRX190345 | MCF-7 Breast | 340 / 19976 (1.7%) | 11670 / 199760 (5.8%) | −173.5 | −171.2 | 0.29 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 895 / 19976 (4.5%) | 2699 / 199760 (1.4%) | −173.3 | −171.1 | 3.32 |
| ESR1 SRX1531796 | MCF-7 Breast | 234 / 19976 (1.2%) | 9779 / 199760 (4.9%) | −173.2 | −170.9 | 0.24 |
| ESR1 SRX20282953 | MCF-7 Breast | 373 / 19976 (1.9%) | 12208 / 199760 (6.1%) | −172.9 | −170.7 | 0.31 |
| FOXA1 SRX3931054 | MCF-7 Breast | 434 / 19976 (2.2%) | 13210 / 199760 (6.6%) | −172.9 | −170.6 | 0.33 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 1117 / 19976 (5.6%) | 23213 / 199760 (11.6%) | −172.8 | −170.6 | 0.48 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 214 / 19976 (1.1%) | 9394 / 199760 (4.7%) | −172.8 | −170.6 | 0.23 |
| MEAF6 DRX234811 | 293 Kidney | 1873 / 19976 (9.4%) | 8823 / 199760 (4.4%) | −172.7 | −170.5 | 2.12 |
| ESR1 SRX330069 | MCF-7 Breast | 275 / 19976 (1.4%) | 10502 / 199760 (5.3%) | −172.5 | −170.2 | 0.26 |
| FOXA1 SRX11222441 | MCF-7 Breast | 358 / 19976 (1.8%) | 11919 / 199760 (6.0%) | −171.8 | −169.5 | 0.30 |
| CDK9 SRX7366783 | MCF-7 Breast | 280 / 19976 (1.4%) | 169 / 199760 (0.1%) | −171.5 | −169.3 | 16.57 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 1088 / 19976 (5.4%) | 22761 / 199760 (11.4%) | −171.5 | −169.2 | 0.48 |
| FOXA1 SRX11222442 | MCF-7 Breast | 307 / 19976 (1.5%) | 11028 / 199760 (5.5%) | −171.3 | −169.1 | 0.28 |
| ESR1 SRX2943589 | MCF-7 Breast | 229 / 19976 (1.1%) | 9617 / 199760 (4.8%) | −170.9 | −168.6 | 0.24 |
| 5-mC SRX882965 | LNCAP Prostate | 2575 / 19976 (12.9%) | 13949 / 199760 (7.0%) | −170.5 | −168.3 | 1.85 |
| FOXA1 SRX028634 | MCF-7 Breast | 221 / 19976 (1.1%) | 9456 / 199760 (4.7%) | −170.4 | −168.2 | 0.23 |
| EP300 SRX176885 | MCF-7 Breast | 235 / 19976 (1.2%) | 9683 / 199760 (4.8%) | −169.4 | −167.2 | 0.24 |
| FOXA1 SRX3923517 | MCF-7 Breast | 328 / 19976 (1.6%) | 11325 / 199760 (5.7%) | −169.2 | −167.0 | 0.29 |
| ESR1 SRX5323871 | MCF-7 Breast | 509 / 19976 (2.5%) | 14274 / 199760 (7.1%) | −169.1 | −166.9 | 0.36 |
| ESR1 SRX371475 | BT-474 Breast | 230 / 19976 (1.2%) | 9578 / 199760 (4.8%) | −169.0 | −166.8 | 0.24 |
| MEAF6 DRX300417 | 293 Kidney | 1717 / 19976 (8.6%) | 7840 / 199760 (3.9%) | −168.9 | −166.7 | 2.19 |
| GATAD2A SRX2636506 | Hep G2 Liver | 608 / 19976 (3.0%) | 15762 / 199760 (7.9%) | −168.1 | −165.9 | 0.39 |
| ESR1 SRX1469949 | MCF-7 Breast | 262 / 19976 (1.3%) | 10133 / 199760 (5.1%) | −168.1 | −165.9 | 0.26 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 428 / 19976 (2.1%) | 12941 / 199760 (6.5%) | −167.9 | −165.7 | 0.33 |
| FOXA1 SRX1787655 | MCF-7 Breast | 227 / 19976 (1.1%) | 9488 / 199760 (4.7%) | −167.9 | −165.7 | 0.24 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 561 / 19976 (2.8%) | 1131 / 199760 (0.6%) | −167.8 | −165.6 | 4.96 |
| FOXA1 SRX11222438 | MCF-7 Breast | 244 / 19976 (1.2%) | 9782 / 199760 (4.9%) | −167.3 | −165.1 | 0.25 |
| AR SRX1067071 | LHSAR Prostate | 947 / 19976 (4.7%) | 20632 / 199760 (10.3%) | −167.2 | −165.0 | 0.46 |
| ESR1 SRX20282938 | MCF-7 Breast | 381 / 19976 (1.9%) | 12136 / 199760 (6.1%) | −166.9 | −164.7 | 0.31 |
| FOXA1 SRX1447317 | MCF-7 Breast | 305 / 19976 (1.5%) | 10850 / 199760 (5.4%) | −166.8 | −164.6 | 0.28 |
| ESR1 SRX371474 | BT-474 Breast | 208 / 19976 (1.0%) | 9096 / 199760 (4.6%) | −166.7 | −164.5 | 0.23 |
| SOX13 SRX2636248 | Hep G2 Liver | 653 / 19976 (3.3%) | 16380 / 199760 (8.2%) | −166.6 | −164.5 | 0.40 |
| FOXA1 SRX1787652 | MCF-7 Breast | 287 / 19976 (1.4%) | 10525 / 199760 (5.3%) | −166.5 | −164.3 | 0.27 |
| ARID5B SRX10475139 | Hep G2 Liver | 517 / 19976 (2.6%) | 14298 / 199760 (7.2%) | −166.3 | −164.1 | 0.36 |
| STAT3 SRX2020842 | HCC70 Breast | 843 / 19976 (4.2%) | 19128 / 199760 (9.6%) | −166.2 | −164.1 | 0.44 |
| AR SRX9469988 | LAPC-4 Prostate | 637 / 19976 (3.2%) | 16121 / 199760 (8.1%) | −166.1 | −163.9 | 0.40 |
| TP53 SRX19538272 | U2OS Bone | 609 / 19976 (3.0%) | 1356 / 199760 (0.7%) | −165.9 | −163.7 | 4.49 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 408 / 19976 (2.0%) | 12526 / 199760 (6.3%) | −165.3 | −163.1 | 0.33 |
| ESR1 SRX1012632 | MCF-7 Breast | 231 / 19976 (1.2%) | 9448 / 199760 (4.7%) | −164.2 | −162.0 | 0.24 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 646 / 19976 (3.2%) | 16182 / 199760 (8.1%) | −164.1 | −161.9 | 0.40 |
| AR SRX9109110 | MDA-MB-453 Breast | 888 / 19976 (4.4%) | 19672 / 199760 (9.8%) | −163.9 | −161.7 | 0.45 |
| FOXA1 SRX3923516 | MCF-7 Breast | 343 / 19976 (1.7%) | 11396 / 199760 (5.7%) | −163.6 | −161.5 | 0.30 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 318 / 19976 (1.6%) | 10966 / 199760 (5.5%) | −163.4 | −161.3 | 0.29 |
| ESR1 SRX5323878 | MCF-7 Breast | 476 / 19976 (2.4%) | 13546 / 199760 (6.8%) | −163.2 | −161.1 | 0.35 |
| FOXA1 SRX100506 | Hep G2 Liver | 640 / 19976 (3.2%) | 16044 / 199760 (8.0%) | −162.8 | −160.7 | 0.40 |
| TEAD1 SRX3401272 | MCF-7 Breast | 368 / 19976 (1.8%) | 11779 / 199760 (5.9%) | −162.6 | −160.4 | 0.31 |
| ESR1 SRX4451212 | MCF-7 Breast | 451 / 19976 (2.3%) | 13127 / 199760 (6.6%) | −162.5 | −160.4 | 0.34 |
| ESR1 SRX8537723 | MCF-7 Breast | 387 / 19976 (1.9%) | 12086 / 199760 (6.1%) | −162.5 | −160.3 | 0.32 |
| KAT6A SRX20971022 | Fibroblasts Others | 239 / 19976 (1.2%) | 107 / 199760 (0.1%) | −162.2 | −160.1 | 22.34 |
| FOXA1 SRX028635 | MCF-7 Breast | 236 / 19976 (1.2%) | 9476 / 199760 (4.7%) | −162.2 | −160.1 | 0.25 |
| ESR1 SRX5323872 | MCF-7 Breast | 482 / 19976 (2.4%) | 13592 / 199760 (6.8%) | −161.9 | −159.7 | 0.35 |
| ESR1 SRX5534831 | MCF-7 Breast | 368 / 19976 (1.8%) | 11756 / 199760 (5.9%) | −161.9 | −159.7 | 0.31 |
| ESR1 SRX3123829 | MCF-7 Breast | 275 / 19976 (1.4%) | 10159 / 199760 (5.1%) | −161.5 | −159.4 | 0.27 |
| FOXA1 SRX3923518 | MCF-7 Breast | 331 / 19976 (1.7%) | 11119 / 199760 (5.6%) | −161.5 | −159.3 | 0.30 |
| PROX1 SRX3230397 | Hep G2 Liver | 353 / 19976 (1.8%) | 11486 / 199760 (5.7%) | −161.2 | −159.1 | 0.31 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 585 / 19976 (2.9%) | 1289 / 199760 (0.6%) | −161.0 | −158.8 | 4.54 |
| FOXA2 SRX100448 | Hep G2 Liver | 537 / 19976 (2.7%) | 14411 / 199760 (7.2%) | −160.9 | −158.8 | 0.37 |
| AR SRX1067070 | LHSAR Prostate | 1177 / 19976 (5.9%) | 23494 / 199760 (11.8%) | −160.5 | −158.4 | 0.50 |
| ESR1 SRX1012629 | MCF-7 Breast | 306 / 19976 (1.5%) | 10657 / 199760 (5.3%) | −160.3 | −158.2 | 0.29 |
| FOXA1 SRX100477 | Hep G2 Liver | 551 / 19976 (2.8%) | 14589 / 199760 (7.3%) | −159.8 | −157.7 | 0.38 |
| ESR1 SRX1469951 | MCF-7 Breast | 250 / 19976 (1.3%) | 9640 / 199760 (4.8%) | −159.3 | −157.1 | 0.26 |
| FOXA1 SRX3931033 | MCF-7 Breast | 308 / 19976 (1.5%) | 10651 / 199760 (5.3%) | −159.1 | −157.0 | 0.29 |
| ESR1 SRX2513520 | MCF-7 Breast | 300 / 19976 (1.5%) | 10487 / 199760 (5.2%) | −158.3 | −156.2 | 0.29 |
| ARID1A SRX5089385 | MCF-7 Breast | 368 / 19976 (1.8%) | 11613 / 199760 (5.8%) | −157.7 | −155.6 | 0.32 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 970 / 19976 (4.9%) | 3317 / 199760 (1.7%) | −157.7 | −155.6 | 2.92 |
| ESR1 SRX20282959 | MCF-7 Breast | 201 / 19976 (1.0%) | 8671 / 199760 (4.3%) | −157.1 | −155.0 | 0.23 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1243 / 19976 (6.2%) | 4973 / 199760 (2.5%) | −156.8 | −154.7 | 2.50 |
| ESR1 SRX2513521 | MCF-7 Breast | 228 / 19976 (1.1%) | 9159 / 199760 (4.6%) | −156.7 | −154.6 | 0.25 |
| GATAD2A SRX2636507 | Hep G2 Liver | 531 / 19976 (2.7%) | 14167 / 199760 (7.1%) | −156.7 | −154.6 | 0.37 |
| EP300 SRX176883 | MCF-7 Breast | 226 / 19976 (1.1%) | 9126 / 199760 (4.6%) | −156.7 | −154.6 | 0.25 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 321 / 19976 (1.6%) | 10784 / 199760 (5.4%) | −156.4 | −154.3 | 0.30 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 854 / 19976 (4.3%) | 18874 / 199760 (9.4%) | −156.0 | −153.9 | 0.45 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2188 / 19976 (11.0%) | 11488 / 199760 (5.8%) | −156.0 | −153.9 | 1.90 |
| ZEB1 SRX13298923 | MCF-7 Breast | 202 / 19976 (1.0%) | 8655 / 199760 (4.3%) | −155.9 | −153.8 | 0.23 |
| ESR1 SRX11120903 | MCF-7 Breast | 427 / 19976 (2.1%) | 12509 / 199760 (6.3%) | −155.8 | −153.7 | 0.34 |
| ZEB1 SRX13298925 | MCF-7 Breast | 305 / 19976 (1.5%) | 10491 / 199760 (5.3%) | −155.7 | −153.6 | 0.29 |
| ESR1 SRX1012633 | MCF-7 Breast | 257 / 19976 (1.3%) | 9639 / 199760 (4.8%) | −155.2 | −153.1 | 0.27 |
| PGR SRX1012655 | MCF-7 Breast | 316 / 19976 (1.6%) | 10659 / 199760 (5.3%) | −155.2 | −153.1 | 0.30 |
| EP300 SRX1012648 | MCF-7 Breast | 237 / 19976 (1.2%) | 9276 / 199760 (4.6%) | −155.1 | −153.0 | 0.26 |
| FOXA1 SRX3931032 | MCF-7 Breast | 285 / 19976 (1.4%) | 10121 / 199760 (5.1%) | −155.1 | −153.0 | 0.28 |
| ESR1 SRX10365534 | MCF-7 Breast | 141 / 19976 (0.7%) | 7436 / 199760 (3.7%) | −154.8 | −152.7 | 0.19 |
| FOXA1 SRX5203303 | MCF-7 Breast | 161 / 19976 (0.8%) | 7837 / 199760 (3.9%) | −154.8 | −152.7 | 0.21 |
| FOXA1 SRX3923519 | MCF-7 Breast | 303 / 19976 (1.5%) | 10417 / 199760 (5.2%) | −154.5 | −152.4 | 0.29 |
| ARID1A SRX5089391 | MCF-7 Breast | 276 / 19976 (1.4%) | 9946 / 199760 (5.0%) | −154.5 | −152.4 | 0.28 |
| ESR1 SRX330068 | MCF-7 Breast | 233 / 19976 (1.2%) | 9179 / 199760 (4.6%) | −154.3 | −152.2 | 0.25 |
| JUN SRX4192884 | MCF 10A Breast | 427 / 19976 (2.1%) | 12453 / 199760 (6.2%) | −154.2 | −152.1 | 0.34 |
| FOXA1 SRX15430999 | T-47D Breast | 550 / 19976 (2.8%) | 14363 / 199760 (7.2%) | −154.2 | −152.1 | 0.38 |
| CDK9 SRX7366781 | MCF-7 Breast | 257 / 19976 (1.3%) | 164 / 199760 (0.1%) | −154.1 | −152.1 | 15.67 |
| ESR1 SRX5323877 | MCF-7 Breast | 389 / 19976 (1.9%) | 11834 / 199760 (5.9%) | −154.1 | −152.0 | 0.33 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 177 / 19976 (0.9%) | 8128 / 199760 (4.1%) | −154.1 | −152.0 | 0.22 |
| HMG20A SRX2630163 | Hep G2 Liver | 280 / 19976 (1.4%) | 10001 / 199760 (5.0%) | −154.0 | −151.9 | 0.28 |
| ESR1 SRX2513517 | MCF-7 Breast | 335 / 19976 (1.7%) | 10934 / 199760 (5.5%) | −153.8 | −151.7 | 0.31 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 467 / 19976 (2.3%) | 13055 / 199760 (6.5%) | −153.4 | −151.3 | 0.36 |
| JUNB SRX4192882 | MCF 10A Breast | 409 / 19976 (2.0%) | 12133 / 199760 (6.1%) | −153.3 | −151.2 | 0.34 |
| ARID1A SRX5089382 | MCF-7 Breast | 353 / 19976 (1.8%) | 11213 / 199760 (5.6%) | −153.2 | −151.1 | 0.31 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 833 / 19976 (4.2%) | 2611 / 199760 (1.3%) | −153.0 | −151.0 | 3.19 |
| ARID5B SRX10475138 | Hep G2 Liver | 823 / 19976 (4.1%) | 18312 / 199760 (9.2%) | −153.0 | −150.9 | 0.45 |
| FOXA1 SRX5323845 | MCF-7 Breast | 177 / 19976 (0.9%) | 8087 / 199760 (4.0%) | −152.7 | −150.6 | 0.22 |
| NFYB SRX16608147 | HeLa Uterus | 277 / 19976 (1.4%) | 216 / 199760 (0.1%) | −152.7 | −150.6 | 12.82 |
| NANOG SRX10445309 | Neural crest cells Neural | 269 / 19976 (1.3%) | 9747 / 199760 (4.9%) | −152.1 | −150.0 | 0.28 |
| BMI1 SRX644729 | 293 Kidney | 249 / 19976 (1.2%) | 153 / 199760 (0.1%) | −151.6 | −149.5 | 16.27 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 336 / 19976 (1.7%) | 10874 / 199760 (5.4%) | −151.5 | −149.5 | 0.31 |
| TFAP2C SRX128099 | MCF-7 Breast | 453 / 19976 (2.3%) | 12764 / 199760 (6.4%) | −151.5 | −149.4 | 0.35 |
| FOXA1 SRX1161203 | T-47D Breast | 363 / 19976 (1.8%) | 11318 / 199760 (5.7%) | −151.3 | −149.3 | 0.32 |
| Epitope tags SRX5877912 | U2OS Bone | 2640 / 19976 (13.2%) | 41290 / 199760 (20.7%) | −151.3 | −149.2 | 0.64 |
| TFAP2C SRX018833 | MCF-7 Breast | 454 / 19976 (2.3%) | 12771 / 199760 (6.4%) | −151.2 | −149.1 | 0.36 |
| ESR1 SRX792933 | LY2 Breast | 413 / 19976 (2.1%) | 12120 / 199760 (6.1%) | −151.1 | −149.0 | 0.34 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 875 / 19976 (4.4%) | 2867 / 199760 (1.4%) | −151.0 | −148.9 | 3.05 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 459 / 19976 (2.3%) | 12838 / 199760 (6.4%) | −150.8 | −148.7 | 0.36 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 158 / 19976 (0.8%) | 7657 / 199760 (3.8%) | −150.7 | −148.6 | 0.21 |
| FOXA1 SRX1961158 | T-47D Breast | 501 / 19976 (2.5%) | 13484 / 199760 (6.8%) | −150.7 | −148.6 | 0.37 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 497 / 19976 (2.5%) | 13410 / 199760 (6.7%) | −150.2 | −148.2 | 0.37 |
| FOXA1 SRX5323846 | MCF-7 Breast | 188 / 19976 (0.9%) | 8214 / 199760 (4.1%) | −150.1 | −148.0 | 0.23 |
| KAT7 DRX234808 | 293 Kidney | 838 / 19976 (4.2%) | 2681 / 199760 (1.3%) | −149.7 | −147.6 | 3.13 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 560 / 19976 (2.8%) | 14340 / 199760 (7.2%) | −149.4 | −147.4 | 0.39 |
| SOX5 SRX2636544 | Hep G2 Liver | 507 / 19976 (2.5%) | 13526 / 199760 (6.8%) | −149.3 | −147.2 | 0.37 |
| FOXA1 SRX5323829 | T-47D Breast | 286 / 19976 (1.4%) | 9939 / 199760 (5.0%) | −148.9 | −146.9 | 0.29 |
| EP300 SRX1012644 | MCF-7 Breast | 233 / 19976 (1.2%) | 9005 / 199760 (4.5%) | −148.8 | −146.7 | 0.26 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 415 / 19976 (2.1%) | 12065 / 199760 (6.0%) | −148.7 | −146.6 | 0.34 |
| GATA3 SRX5457550 | MCF-7 Breast | 574 / 19976 (2.9%) | 14517 / 199760 (7.3%) | −148.6 | −146.6 | 0.40 |
| FOXA1 SRX3931056 | MCF-7 Breast | 302 / 19976 (1.5%) | 10188 / 199760 (5.1%) | −148.1 | −146.0 | 0.30 |
| ESR1 SRX176856 | MCF-7 Breast | 173 / 19976 (0.9%) | 7867 / 199760 (3.9%) | −148.0 | −145.9 | 0.22 |
| FOXA1 SRX1961157 | T-47D Breast | 554 / 19976 (2.8%) | 14185 / 199760 (7.1%) | −147.7 | −145.7 | 0.39 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 290 / 19976 (1.5%) | 9969 / 199760 (5.0%) | −147.6 | −145.6 | 0.29 |
| AR SRX9109113 | MDA-MB-453 Breast | 951 / 19976 (4.8%) | 19862 / 199760 (9.9%) | −147.4 | −145.4 | 0.48 |
| FOXA1 SRX1787654 | MCF-7 Breast | 190 / 19976 (1.0%) | 8164 / 199760 (4.1%) | −147.2 | −145.2 | 0.23 |
| ESR1 SRX2881001 | MCF-7 Breast | 283 / 19976 (1.4%) | 9832 / 199760 (4.9%) | −147.2 | −145.2 | 0.29 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 488 / 19976 (2.4%) | 13135 / 199760 (6.6%) | −146.6 | −144.5 | 0.37 |
| ESR1 SRX2513519 | MCF-7 Breast | 278 / 19976 (1.4%) | 9725 / 199760 (4.9%) | −146.6 | −144.5 | 0.29 |
| ESR1 SRX1012630 | MCF-7 Breast | 199 / 19976 (1.0%) | 8312 / 199760 (4.2%) | −146.5 | −144.5 | 0.24 |
| FOXA1 SRX5323830 | T-47D Breast | 307 / 19976 (1.5%) | 10221 / 199760 (5.1%) | −146.5 | −144.5 | 0.30 |
| JUNB SRX10119386 | MCF 10A Breast | 475 / 19976 (2.4%) | 12915 / 199760 (6.5%) | −146.1 | −144.1 | 0.37 |
| FOXA1 SRX3923515 | MCF-7 Breast | 291 / 19976 (1.5%) | 9930 / 199760 (5.0%) | −146.1 | −144.0 | 0.29 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 980 / 19976 (4.9%) | 20201 / 199760 (10.1%) | −146.0 | −144.0 | 0.49 |
| ESR1 SRX5534832 | MCF-7 Breast | 473 / 19976 (2.4%) | 12873 / 199760 (6.4%) | −145.7 | −143.7 | 0.37 |
| NR3C1 SRX19024866 | MCF-7 Breast | 179 / 19976 (0.9%) | 7911 / 199760 (4.0%) | −145.6 | −143.6 | 0.23 |
| VGLL1 SRX18013277 | FULVR Breast | 219 / 19976 (1.1%) | 8651 / 199760 (4.3%) | −145.6 | −143.5 | 0.25 |
| FOXA1 SRX3923511 | MCF-7 Breast | 196 / 19976 (1.0%) | 8218 / 199760 (4.1%) | −145.3 | −143.3 | 0.24 |
| FOXA3 SRX2630190 | Hep G2 Liver | 434 / 19976 (2.2%) | 12243 / 199760 (6.1%) | −145.1 | −143.1 | 0.35 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 369 / 19976 (1.8%) | 11191 / 199760 (5.6%) | −144.9 | −142.9 | 0.33 |
| NFIL3 SRX2630334 | Hep G2 Liver | 416 / 19976 (2.1%) | 11947 / 199760 (6.0%) | −144.8 | −142.8 | 0.35 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 745 / 19976 (3.7%) | 16868 / 199760 (8.4%) | −144.7 | −142.7 | 0.44 |
| CEBPA SRX4705113 | MOLM-13 Blood | 1143 / 19976 (5.7%) | 22331 / 199760 (11.2%) | −144.6 | −142.6 | 0.51 |
| FOXA2 SRX10475773 | Hep G2 Liver | 628 / 19976 (3.1%) | 15149 / 199760 (7.6%) | −144.1 | −142.1 | 0.41 |
| ESR1 SRX5323874 | MCF-7 Breast | 312 / 19976 (1.6%) | 10218 / 199760 (5.1%) | −144.0 | −142.0 | 0.31 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 144 / 19976 (0.7%) | 7163 / 199760 (3.6%) | −143.4 | −141.4 | 0.20 |
| ESR1 SRX4451214 | MCF-7 Breast | 453 / 19976 (2.3%) | 12467 / 199760 (6.2%) | −143.2 | −141.2 | 0.36 |
| FOXA1 SRX5203307 | MCF-7 Breast | 154 / 19976 (0.8%) | 7349 / 199760 (3.7%) | −143.1 | −141.1 | 0.21 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 779 / 19976 (3.9%) | 2447 / 199760 (1.2%) | −142.6 | −140.6 | 3.18 |
| CBX3 SRX6712570 | MCF-7 Breast | 410 / 19976 (2.1%) | 11767 / 199760 (5.9%) | −142.5 | −140.5 | 0.35 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 507 / 19976 (2.5%) | 13270 / 199760 (6.6%) | −142.3 | −140.3 | 0.38 |
| STAT3 SRX150536 | MCF 10A Breast | 584 / 19976 (2.9%) | 14424 / 199760 (7.2%) | −142.1 | −140.1 | 0.40 |
| ESR1 SRX3110723 | MCF-7 Breast | 291 / 19976 (1.5%) | 9796 / 199760 (4.9%) | −142.0 | −140.0 | 0.30 |
| FOXA1 SRX1447316 | MCF-7 Breast | 226 / 19976 (1.1%) | 8656 / 199760 (4.3%) | −141.8 | −139.8 | 0.26 |
| RELA SRX5938177 | FaDu Others | 493 / 19976 (2.5%) | 13034 / 199760 (6.5%) | −141.7 | −139.7 | 0.38 |
| EP300 SRX1012643 | MCF-7 Breast | 195 / 19976 (1.0%) | 8081 / 199760 (4.0%) | −141.5 | −139.5 | 0.24 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 456 / 19976 (2.3%) | 12450 / 199760 (6.2%) | −141.4 | −139.4 | 0.37 |
| ARID1A SRX5089388 | MCF-7 Breast | 271 / 19976 (1.4%) | 9424 / 199760 (4.7%) | −141.0 | −139.1 | 0.29 |
| FOS SRX3322636 | MCF-7 Breast | 354 / 19976 (1.8%) | 10814 / 199760 (5.4%) | −141.0 | −139.0 | 0.33 |
| ESR1 SRX1012625 | MCF-7 Breast | 283 / 19976 (1.4%) | 9631 / 199760 (4.8%) | −141.0 | −139.0 | 0.29 |
| ESR1 SRX1995229 | MCF-7 Breast | 522 / 19976 (2.6%) | 13442 / 199760 (6.7%) | −140.8 | −138.9 | 0.39 |
| NR3C1 SRX8520802 | HCC1187 Breast | 396 / 19976 (2.0%) | 11484 / 199760 (5.7%) | −140.8 | −138.8 | 0.34 |
| NR3C1 SRX19024870 | MCF-7 Breast | 176 / 19976 (0.9%) | 7705 / 199760 (3.9%) | −140.8 | −138.8 | 0.23 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 400 / 19976 (2.0%) | 11533 / 199760 (5.8%) | −140.4 | −138.4 | 0.35 |
| KAT7 DRX300414 | 293 Kidney | 666 / 19976 (3.3%) | 1874 / 199760 (0.9%) | −140.4 | −138.4 | 3.55 |
| GATA3 SRX100559 | T-47D Breast | 577 / 19976 (2.9%) | 14248 / 199760 (7.1%) | −140.3 | −138.3 | 0.40 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 494 / 19976 (2.5%) | 12981 / 199760 (6.5%) | −139.9 | −137.9 | 0.38 |
| STAT3 SRX150630 | MCF 10A Breast | 494 / 19976 (2.5%) | 12982 / 199760 (6.5%) | −139.9 | −137.9 | 0.38 |
| SSRP1 SRX3436567 | HT-1080 Bone | 403 / 19976 (2.0%) | 681 / 199760 (0.3%) | −139.8 | −137.9 | 5.92 |
| RXRB SRX2636027 | Hep G2 Liver | 568 / 19976 (2.8%) | 14094 / 199760 (7.1%) | −139.7 | −137.8 | 0.40 |
| EP300 SRX150579 | HeLa Uterus | 361 / 19976 (1.8%) | 10882 / 199760 (5.4%) | −139.7 | −137.7 | 0.33 |
| Epitope tags SRX10549778 | K-562 Blood | 1166 / 19976 (5.8%) | 4792 / 199760 (2.4%) | −139.7 | −137.7 | 2.43 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 207 / 19976 (1.0%) | 8239 / 199760 (4.1%) | −139.5 | −137.5 | 0.25 |
| FOXA1 SRX6878603 | LNCAP Prostate | 582 / 19976 (2.9%) | 14285 / 199760 (7.2%) | −139.4 | −137.4 | 0.41 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1145 / 19976 (5.7%) | 22122 / 199760 (11.1%) | −139.4 | −137.4 | 0.52 |
| ESR1 SRX1469950 | MCF-7 Breast | 198 / 19976 (1.0%) | 8074 / 199760 (4.0%) | −139.4 | −137.4 | 0.25 |
| ESR1 SRX20282966 | MCF-7 Breast | 193 / 19976 (1.0%) | 7979 / 199760 (4.0%) | −139.3 | −137.3 | 0.24 |
| ZEB1 SRX13298924 | MCF-7 Breast | 264 / 19976 (1.3%) | 9237 / 199760 (4.6%) | −139.1 | −137.1 | 0.29 |
| STAT3 SRX150479 | MCF 10A Breast | 500 / 19976 (2.5%) | 13035 / 199760 (6.5%) | −139.0 | −137.0 | 0.38 |
| FOXA1 SRX5203294 | MCF-7 Breast | 154 / 19976 (0.8%) | 7225 / 199760 (3.6%) | −138.8 | −136.8 | 0.21 |
| JUNB SRX8488073 | SUM 229PE Breast | 972 / 19976 (4.9%) | 19774 / 199760 (9.9%) | −138.7 | −136.8 | 0.49 |
| ESR1 SRX1012628 | MCF-7 Breast | 278 / 19976 (1.4%) | 9465 / 199760 (4.7%) | −138.7 | −136.7 | 0.29 |
| YAP1 SRX5718140 | 293 Kidney | 890 / 19976 (4.5%) | 18644 / 199760 (9.3%) | −138.6 | −136.7 | 0.48 |
| TRPS1 SRX3401273 | MCF-7 Breast | 176 / 19976 (0.9%) | 7636 / 199760 (3.8%) | −138.6 | −136.6 | 0.23 |
| CHD7 SRX3581504 | iPS cells Pluripotent stem cell | 109 / 19976 (0.5%) | 6306 / 199760 (3.2%) | −138.5 | −136.6 | 0.17 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 155 / 19976 (0.8%) | 7223 / 199760 (3.6%) | −138.1 | −136.1 | 0.21 |
| NCOA3 SRX4663589 | MCF-7 Breast | 150 / 19976 (0.8%) | 7123 / 199760 (3.6%) | −138.0 | −136.0 | 0.21 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 507 / 19976 (2.5%) | 13106 / 199760 (6.6%) | −137.9 | −135.9 | 0.39 |
| SS18 SRX3468047 | Fibroblasts Others | 1279 / 19976 (6.4%) | 23804 / 199760 (11.9%) | −137.8 | −135.8 | 0.54 |
| ESR1 SRX5287697 | MCF-7 Breast | 196 / 19976 (1.0%) | 7979 / 199760 (4.0%) | −137.6 | −135.7 | 0.25 |
| ESR1 SRX5323876 | MCF-7 Breast | 288 / 19976 (1.4%) | 9596 / 199760 (4.8%) | −137.5 | −135.6 | 0.30 |
| JADE3 DRX300415 | 293 Kidney | 1617 / 19976 (8.1%) | 7869 / 199760 (3.9%) | −137.2 | −135.3 | 2.05 |
| ESR1 SRX3123823 | MCF-7 Breast | 191 / 19976 (1.0%) | 7879 / 199760 (3.9%) | −137.2 | −135.3 | 0.24 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 680 / 19976 (3.4%) | 15629 / 199760 (7.8%) | −137.1 | −135.2 | 0.44 |
| Epitope tags SRX5877914 | U2OS Bone | 2682 / 19976 (13.4%) | 40988 / 199760 (20.5%) | −137.1 | −135.1 | 0.65 |
| SMARCA2 SRX8119677 | MeT-5A Others | 863 / 19976 (4.3%) | 18203 / 199760 (9.1%) | −137.0 | −135.1 | 0.47 |
| ESR1 SRX3110720 | MCF-7 Breast | 229 / 19976 (1.1%) | 8553 / 199760 (4.3%) | −136.9 | −134.9 | 0.27 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 464 / 19976 (2.3%) | 12405 / 199760 (6.2%) | −136.8 | −134.8 | 0.37 |
| EP300 SRX100544 | Hep G2 Liver | 413 / 19976 (2.1%) | 11607 / 199760 (5.8%) | −136.7 | −134.7 | 0.36 |
| Epitope tags SRX20741925 | Hep G2 Liver | 899 / 19976 (4.5%) | 18680 / 199760 (9.4%) | −136.6 | −134.7 | 0.48 |
| CEBPB SRX2194250 | SUM 159PT Breast | 644 / 19976 (3.2%) | 15082 / 199760 (7.6%) | −136.4 | −134.5 | 0.43 |
| ESR1 SRX2513518 | MCF-7 Breast | 267 / 19976 (1.3%) | 9196 / 199760 (4.6%) | −136.3 | −134.3 | 0.29 |
| TET2 SRX8617001 | MCF-7 Breast | 358 / 19976 (1.8%) | 10715 / 199760 (5.4%) | −136.3 | −134.3 | 0.33 |
| MAU2 SRX11120892 | MCF-7 Breast | 227 / 19976 (1.1%) | 8496 / 199760 (4.3%) | −136.1 | −134.2 | 0.27 |
| ZNF219 SRX3230413 | Hep G2 Liver | 897 / 19976 (4.5%) | 18627 / 199760 (9.3%) | −135.9 | −134.0 | 0.48 |
| ESR1 SRX9719167 | MCF-7 Breast | 248 / 19976 (1.2%) | 8857 / 199760 (4.4%) | −135.9 | −134.0 | 0.28 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 560 / 19976 (2.8%) | 13813 / 199760 (6.9%) | −135.6 | −133.7 | 0.41 |
| FOXA1 SRX1161205 | T-47D Breast | 298 / 19976 (1.5%) | 9699 / 199760 (4.9%) | −135.5 | −133.6 | 0.31 |
| ESR1 SRX5089450 | MCF-7 Breast | 296 / 19976 (1.5%) | 9656 / 199760 (4.8%) | −135.2 | −133.3 | 0.31 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 133 / 19976 (0.7%) | 6700 / 199760 (3.4%) | −135.2 | −133.3 | 0.20 |
| AR SRX9109109 | MDA-MB-453 Breast | 624 / 19976 (3.1%) | 14736 / 199760 (7.4%) | −135.1 | −133.2 | 0.42 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 690 / 19976 (3.5%) | 2060 / 199760 (1.0%) | −135.0 | −133.1 | 3.35 |
| SMARCA4 SRX5212362 | Mel270 Others | 908 / 19976 (4.5%) | 18717 / 199760 (9.4%) | −134.6 | −132.7 | 0.49 |
| VGLL1 SRX24602130 | BT-20 Breast | 574 / 19976 (2.9%) | 13972 / 199760 (7.0%) | −134.3 | −132.4 | 0.41 |
| ESR1 SRX3080214 | MCF-7 Breast | 136 / 19976 (0.7%) | 6734 / 199760 (3.4%) | −134.2 | −132.3 | 0.20 |
| AHR SRX20282969 | MCF-7 Breast | 259 / 19976 (1.3%) | 8987 / 199760 (4.5%) | −134.1 | −132.1 | 0.29 |
| ESR1 SRX5089447 | MCF-7 Breast | 258 / 19976 (1.3%) | 8961 / 199760 (4.5%) | −133.8 | −131.9 | 0.29 |
| GFP SRX6949256 | HeLa Uterus | 596 / 19976 (3.0%) | 14269 / 199760 (7.1%) | −133.6 | −131.7 | 0.42 |
| MAU2 SRX11120893 | MCF-7 Breast | 227 / 19976 (1.1%) | 8412 / 199760 (4.2%) | −133.5 | −131.6 | 0.27 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 388 / 19976 (1.9%) | 11095 / 199760 (5.6%) | −133.5 | −131.6 | 0.35 |
| HDAC2 SRX190281 | MCF-7 Breast | 472 / 19976 (2.4%) | 12403 / 199760 (6.2%) | −133.4 | −131.4 | 0.38 |
| KDM6A SRX15826236 | MCF-7 Breast | 180 / 19976 (0.9%) | 7555 / 199760 (3.8%) | −133.3 | −131.4 | 0.24 |
| STAT1 SRX23678708 | K-562 Blood | 1614 / 19976 (8.1%) | 7945 / 199760 (4.0%) | −133.3 | −131.4 | 2.03 |
| JUND SRX150648 | K-562 Blood | 703 / 19976 (3.5%) | 15794 / 199760 (7.9%) | −133.1 | −131.2 | 0.45 |
| ESR1 SRX1012631 | MCF-7 Breast | 249 / 19976 (1.2%) | 8782 / 199760 (4.4%) | −133.1 | −131.2 | 0.28 |
| CEBPA SRX2630242 | Hep G2 Liver | 268 / 19976 (1.3%) | 9107 / 199760 (4.6%) | −133.0 | −131.1 | 0.29 |
| STAT3 SRX5323860 | MCF-7 Breast | 665 / 19976 (3.3%) | 15246 / 199760 (7.6%) | −133.0 | −131.1 | 0.44 |
| JUND SRX092301 | K-562 Blood | 701 / 19976 (3.5%) | 15760 / 199760 (7.9%) | −133.0 | −131.1 | 0.44 |
| FOXA1 SRX5323844 | MCF-7 Breast | 158 / 19976 (0.8%) | 7120 / 199760 (3.6%) | −132.9 | −131.0 | 0.22 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 454 / 19976 (2.3%) | 12107 / 199760 (6.1%) | −132.8 | −130.9 | 0.37 |
| ESR1 SRX7624162 | T-47D Breast | 312 / 19976 (1.6%) | 9845 / 199760 (4.9%) | −132.8 | −130.9 | 0.32 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 348 / 19976 (1.7%) | 10428 / 199760 (5.2%) | −132.8 | −130.9 | 0.33 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1679 / 19976 (8.4%) | 28645 / 199760 (14.3%) | −132.7 | −130.8 | 0.59 |
| EP300 SRX2671806 | iPS cells Pluripotent stem cell | 116 / 19976 (0.6%) | 6279 / 199760 (3.1%) | −132.5 | −130.6 | 0.18 |
| FOXA3 SRX2630189 | Hep G2 Liver | 439 / 19976 (2.2%) | 11864 / 199760 (5.9%) | −132.5 | −130.6 | 0.37 |
| FOXA1 SRX3931031 | MCF-7 Breast | 264 / 19976 (1.3%) | 9023 / 199760 (4.5%) | −132.5 | −130.6 | 0.29 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 238 / 19976 (1.2%) | 8570 / 199760 (4.3%) | −132.4 | −130.5 | 0.28 |
| ESR1 SRX3123830 | MCF-7 Breast | 160 / 19976 (0.8%) | 7144 / 199760 (3.6%) | −132.4 | −130.5 | 0.22 |
| CEBPA SRX097095 | U-937 Blood | 417 / 19976 (2.1%) | 11510 / 199760 (5.8%) | −132.2 | −130.3 | 0.36 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 1104 / 19976 (5.5%) | 21249 / 199760 (10.6%) | −132.2 | −130.3 | 0.52 |
| FOXA1 SRX8537736 | MCF-7 Breast | 199 / 19976 (1.0%) | 7864 / 199760 (3.9%) | −132.2 | −130.3 | 0.25 |
| FOXA1 SRX9604647 | LNCAP Prostate | 801 / 19976 (4.0%) | 17124 / 199760 (8.6%) | −131.9 | −130.0 | 0.47 |
| AR SRX15946405 | MDA-MB-453 Breast | 355 / 19976 (1.8%) | 10510 / 199760 (5.3%) | −131.9 | −130.0 | 0.34 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 288 / 19976 (1.4%) | 9407 / 199760 (4.7%) | −131.8 | −129.9 | 0.31 |
| GATA3 SRX190194 | SK-N-SH Neural | 1227 / 19976 (6.1%) | 22841 / 199760 (11.4%) | −131.7 | −129.8 | 0.54 |
| AR SRX11149848 | MDA-MB-453 Breast | 356 / 19976 (1.8%) | 10516 / 199760 (5.3%) | −131.6 | −129.7 | 0.34 |
| KMT2C SRX1787675 | MCF-7 Breast | 487 / 19976 (2.4%) | 12553 / 199760 (6.3%) | −131.4 | −129.5 | 0.39 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 635 / 19976 (3.2%) | 14741 / 199760 (7.4%) | −131.3 | −129.4 | 0.43 |
| ESR1 SRX968963 | MCF-7 Breast | 230 / 19976 (1.2%) | 8382 / 199760 (4.2%) | −131.0 | −129.1 | 0.27 |
| ESR1 SRX1995230 | MCF-7 Breast | 465 / 19976 (2.3%) | 12201 / 199760 (6.1%) | −130.9 | −129.0 | 0.38 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 635 / 19976 (3.2%) | 14725 / 199760 (7.4%) | −130.8 | −128.9 | 0.43 |
| FOXA1 SRX3923508 | MCF-7 Breast | 179 / 19976 (0.9%) | 7455 / 199760 (3.7%) | −130.8 | −128.9 | 0.24 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1247 / 19976 (6.2%) | 23053 / 199760 (11.5%) | −130.7 | −128.8 | 0.54 |
| ESR1 SRX1585242 | MCF-7 Breast | 213 / 19976 (1.1%) | 8073 / 199760 (4.0%) | −130.7 | −128.8 | 0.26 |
| JUNB SRX8488089 | SUM 229PE Breast | 563 / 19976 (2.8%) | 13666 / 199760 (6.8%) | −130.6 | −128.8 | 0.41 |
| FOXA1 SRX3923510 | MCF-7 Breast | 217 / 19976 (1.1%) | 8141 / 199760 (4.1%) | −130.6 | −128.8 | 0.27 |
| CIC SRX13262055 | Astrocytes Neural | 3147 / 19976 (15.8%) | 19782 / 199760 (9.9%) | −130.4 | −128.5 | 1.59 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 166 / 19976 (0.8%) | 7199 / 199760 (3.6%) | −130.3 | −128.5 | 0.23 |
| FOXA1 SRX1161207 | T-47D Breast | 237 / 19976 (1.2%) | 8483 / 199760 (4.2%) | −130.3 | −128.5 | 0.28 |
| CEBPB SRX3584202 | Epididymis Gonad | 508 / 19976 (2.5%) | 12823 / 199760 (6.4%) | −130.1 | −128.2 | 0.40 |
| AR SRX1067067 | LHSAR Prostate | 913 / 19976 (4.6%) | 18585 / 199760 (9.3%) | −130.0 | −128.1 | 0.49 |
| CEBPB SRX2194249 | SUM 159PT Breast | 540 / 19976 (2.7%) | 13297 / 199760 (6.7%) | −130.0 | −128.1 | 0.41 |
| JADE3 DRX234809 | 293 Kidney | 1066 / 19976 (5.3%) | 4338 / 199760 (2.2%) | −129.8 | −128.0 | 2.46 |
| FOXA1 SRX1161172 | MCF-7 Breast | 557 / 19976 (2.8%) | 13542 / 199760 (6.8%) | −129.8 | −127.9 | 0.41 |
| SMARCC1 SRX3927288 | EOL-1 Blood | 1273 / 19976 (6.4%) | 23337 / 199760 (11.7%) | −129.5 | −127.7 | 0.55 |
| FOXA1 SRX3931073 | MCF-7 Breast | 334 / 19976 (1.7%) | 10088 / 199760 (5.1%) | −129.5 | −127.6 | 0.33 |
| FOXA1 SRX8537737 | MCF-7 Breast | 221 / 19976 (1.1%) | 8174 / 199760 (4.1%) | −129.4 | −127.6 | 0.27 |
| ESR1 SRX176858 | MCF-7 Breast | 195 / 19976 (1.0%) | 7699 / 199760 (3.9%) | −129.2 | −127.4 | 0.25 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 565 / 19976 (2.8%) | 13640 / 199760 (6.8%) | −129.2 | −127.3 | 0.41 |
| ESR1 SRX20282967 | MCF-7 Breast | 179 / 19976 (0.9%) | 7403 / 199760 (3.7%) | −129.2 | −127.3 | 0.24 |
| SMARCA4 SRX5212357 | Mel270 Others | 788 / 19976 (3.9%) | 16830 / 199760 (8.4%) | −129.2 | −127.3 | 0.47 |
| AHR SRX2378695 | MCF-7 Breast | 246 / 19976 (1.2%) | 8600 / 199760 (4.3%) | −129.1 | −127.2 | 0.29 |
| GATA3 SRX6712580 | MCF-7 Breast | 164 / 19976 (0.8%) | 7116 / 199760 (3.6%) | −128.9 | −127.0 | 0.23 |
| ESR1 SRX7624161 | T-47D Breast | 322 / 19976 (1.6%) | 9869 / 199760 (4.9%) | −128.9 | −127.0 | 0.33 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 641 / 19976 (3.2%) | 14730 / 199760 (7.4%) | −128.8 | −127.0 | 0.44 |
| FOXA1 SRX6860635 | T-47D Breast | 425 / 19976 (2.1%) | 11491 / 199760 (5.8%) | −128.4 | −126.5 | 0.37 |
| FOXA1 SRX190181 | A549 Lung | 410 / 19976 (2.1%) | 11257 / 199760 (5.6%) | −128.3 | −126.5 | 0.36 |
| ESR1 SRX5323875 | MCF-7 Breast | 216 / 19976 (1.1%) | 8037 / 199760 (4.0%) | −128.0 | −126.1 | 0.27 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 1037 / 19976 (5.2%) | 20159 / 199760 (10.1%) | −127.9 | −126.0 | 0.51 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 214 / 19976 (1.1%) | 7997 / 199760 (4.0%) | −127.8 | −125.9 | 0.27 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 373 / 19976 (1.9%) | 10652 / 199760 (5.3%) | −127.8 | −125.9 | 0.35 |
| FOXA1 SRX15431000 | T-47D Breast | 457 / 19976 (2.3%) | 11958 / 199760 (6.0%) | −127.7 | −125.8 | 0.38 |
| ARID1A SRX5089380 | MCF-7 Breast | 213 / 19976 (1.1%) | 7972 / 199760 (4.0%) | −127.6 | −125.7 | 0.27 |
| FOXA1 SRX5323828 | T-47D Breast | 237 / 19976 (1.2%) | 8383 / 199760 (4.2%) | −127.2 | −125.4 | 0.28 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 529 / 19976 (2.6%) | 13029 / 199760 (6.5%) | −127.2 | −125.3 | 0.41 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 1257 / 19976 (6.3%) | 23009 / 199760 (11.5%) | −127.1 | −125.2 | 0.55 |
| FOXA1 SRX3923513 | MCF-7 Breast | 182 / 19976 (0.9%) | 7393 / 199760 (3.7%) | −127.1 | −125.2 | 0.25 |
| FOXA1 SRX9604645 | LNCAP Prostate | 759 / 19976 (3.8%) | 16314 / 199760 (8.2%) | −126.6 | −124.7 | 0.47 |
| TET2 SRX8617003 | MCF-7 Breast | 195 / 19976 (1.0%) | 7612 / 199760 (3.8%) | −126.5 | −124.6 | 0.26 |
| RAD21 SRX2630139 | Hep G2 Liver | 637 / 19976 (3.2%) | 14569 / 199760 (7.3%) | −126.2 | −124.4 | 0.44 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 941 / 19976 (4.7%) | 18790 / 199760 (9.4%) | −126.1 | −124.2 | 0.50 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 507 / 19976 (2.5%) | 12643 / 199760 (6.3%) | −125.7 | −123.9 | 0.40 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 358 / 19976 (1.8%) | 10326 / 199760 (5.2%) | −125.2 | −123.4 | 0.35 |
| ESR1 SRX3080213 | MCF-7 Breast | 159 / 19976 (0.8%) | 6906 / 199760 (3.5%) | −125.2 | −123.3 | 0.23 |
| EP300 ERX626821 | U-937 Blood | 1256 / 19976 (6.3%) | 5669 / 199760 (2.8%) | −125.0 | −123.2 | 2.22 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 556 / 19976 (2.8%) | 13342 / 199760 (6.7%) | −125.0 | −123.2 | 0.42 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1694 / 19976 (8.5%) | 28423 / 199760 (14.2%) | −124.9 | −123.0 | 0.60 |
| Epitope tags SRX1165091 | Hep G2 Liver | 565 / 19976 (2.8%) | 13462 / 199760 (6.7%) | −124.7 | −122.9 | 0.42 |
| EP300 SRX176884 | MCF-7 Breast | 125 / 19976 (0.6%) | 6231 / 199760 (3.1%) | −124.7 | −122.8 | 0.20 |
| SMARCA4 SRX5212366 | Mel270 Others | 752 / 19976 (3.8%) | 16130 / 199760 (8.1%) | −124.6 | −122.8 | 0.47 |
| Epitope tags SRX1165090 | Hep G2 Liver | 641 / 19976 (3.2%) | 14559 / 199760 (7.3%) | −124.5 | −122.7 | 0.44 |
| GATA3 SRX11149845 | MDA-MB-453 Breast | 577 / 19976 (2.9%) | 13626 / 199760 (6.8%) | −124.5 | −122.7 | 0.42 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 295 / 19976 (1.5%) | 9272 / 199760 (4.6%) | −124.4 | −122.6 | 0.32 |
| VGLL1 SRX18013278 | FULVR Breast | 286 / 19976 (1.4%) | 9120 / 199760 (4.6%) | −124.3 | −122.5 | 0.31 |
| NKX2-1 SRX2164786 | A549 Lung | 893 / 19976 (4.5%) | 18053 / 199760 (9.0%) | −124.1 | −122.3 | 0.49 |
| FOXA1 SRX3923509 | MCF-7 Breast | 175 / 19976 (0.9%) | 7173 / 199760 (3.6%) | −124.0 | −122.2 | 0.24 |
| ESR1 SRX20282945 | MCF-7 Breast | 159 / 19976 (0.8%) | 6864 / 199760 (3.4%) | −123.8 | −122.0 | 0.23 |
| NR3C1 SRX1161167 | MCF-7 Breast | 158 / 19976 (0.8%) | 6847 / 199760 (3.4%) | −123.8 | −121.9 | 0.23 |
| VGLL1 SRX18013279 | FULVR Breast | 285 / 19976 (1.4%) | 9082 / 199760 (4.5%) | −123.7 | −121.9 | 0.31 |
| FOXA2 SRX10475774 | Hep G2 Liver | 265 / 19976 (1.3%) | 8742 / 199760 (4.4%) | −123.5 | −121.7 | 0.30 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 598 / 19976 (3.0%) | 13898 / 199760 (7.0%) | −123.5 | −121.7 | 0.43 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 386 / 19976 (1.9%) | 10703 / 199760 (5.4%) | −123.4 | −121.6 | 0.36 |
| RAD21 SRX2630140 | Hep G2 Liver | 568 / 19976 (2.8%) | 13449 / 199760 (6.7%) | −123.3 | −121.5 | 0.42 |
| TCF12 SRX190356 | SK-N-SH Neural | 1421 / 19976 (7.1%) | 24912 / 199760 (12.5%) | −123.1 | −121.3 | 0.57 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 782 / 19976 (3.9%) | 16480 / 199760 (8.2%) | −123.1 | −121.2 | 0.47 |
Showing first 500 of 17313 rows.